Evaluation of the orally bioavailable 4-phenylbutyrate-tethered trichostatin A analogue AR42 in models of spinal muscular atrophy

Lumpkin, C. J., Harris, A. W., Connell, A. J., Kirk, R. W., Whiting, J. A., Saieva, L., Pellizzoni, L., Burghes, A. H. M., & Butchbach, M. E. R. (2023). Evaluation of the orally bioavailable 4-phenylbutyrate-tethered trichostatin A analogue AR42 in models of spinal muscular atrophy. Scientific Reports, 13(1). https://doi.org/10.1038/s41598-023-37496-0
Authors:
Casey J. Lumpkin
Ashlee W. Harris
Andrew J. Connell
Ryan W. Kirk
Joshua A. Whiting
Luciano Saieva
Livio Pellizzoni
Arthur H. M. Burghes
Matthew E. R. Butchbach
Affiliated Authors:
Luciano Saieva
Livio Pellizzoni
Publication Type:
Article
Unique ID:
10.1038/s41598-023-37496-0
PMID:
Publication Date:
Data Source:
Scopus

Record Created: